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Background: Many differentiating tissues contain pro-
genitor cells that differ in their commitment states but
cannot be readily distinguished or segregated. Molecular
analysis is therefore restricted to mixed populations or cell
lines which may also be heterogeneous, and the critical
differences in gene expression that might determine
divergent development are obscured. In this study, we
combined global amplification of mRNA transcripts in
single cells with identification of the developmental
potential of processed cells on the basis of the fates of
their sibling cells from clonal starts.
Results: We analyzed clones of from four to eight
hemopoietic precursor cells which had a variety of differ-
entiative potentials; sibling cells generally each formed
clones of identical composition in secondary culture.
Globally amplified cDNA was prepared from individual
precursors whose developmental potential was identified
by tracking sibling fates. Further cDNA samples were
prepared from terminally maturing, homogeneous hemo-
poietic cell populations. Together, the samples repre-
sented 16 positions in the hemopoietic developmental
hierarchy. Expression patterns in the sample set were
determined for 29 genes known to be involved in
hemopoietic cell growth, differentiation or function. The
cDNAs from a bipotent erythroid/megakaryocyte precur-
sor and a bipotent neutrophil/macrophage precursor were
subtractively hybridized, yielding numerous differentially
expressed cDNA clones. Hybridization of such clones
to the entire precursor sample set identified transcripts
with consistent patterns of differential expression in the
precursor hierarchy.
Conclusions: Tracking of sibling fates reliably identifies
the differentiative potential of a single cell taken for PCR
analysis, and demonstrates the existence of a variety of
distinct and stable states of differentiative commitment.
Global amplification of cDNA from single precursor cells,
identified by sibling fates, yields a true representation of
lineage- and stage-specific gene expression, as confirmed
by hybridization to a broad panel of probes. The results
provide the first expression mapping of these genes that
distinguishes between progenitors in different commit-
ment states, generate new insights and predictions rel-
evant to mechanism, and introduce a powerful set of tools
for unravelling the genetic basis of lineage divergence.
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Background
The progression of cells along developmental pathways is
defined and driven by changes in gene expression. Iden-
tification of these changes would provide the keys to
understanding the mechanisms of differentiative progres-
sion. But the quest for such information is frequently
complicated by the heterogeneous composition of dif-
ferentiating tissues. Hemopoietic tissues are typical of
developmental and cell-renewal systems in which differ-
entiative decisions take place within rare precursor cells
that are structurally indistinguishable and greatly out-
numbered amongst their maturing progeny. Neverthe-
less, it is possible to detect hemopoietic precursor cells in
functional assays, and to distinguish precursors that differ
in their differentiative and growth potentials on the basis
of the composition of the clones that they can generate.
Such assays define a hierarchy of hemopoietic precursors
extending from multipotential stem cells through pluri-
potential and oligopotential intermediates, to cells that
are committed uniquely to forming one of a dozen
alternative blood and tissue cell types.
Methods of cell separation can purify precursor cells
from more differentiated progeny, but have not been par-
ticularly effective in separating early precursor cells from
others that differ in their commitment states [1]. Mol-
ecular analysis of this system has therefore been limited to
the study of precursor populations of mixed composition,
or of cell lines which often comprise a mixture of cells in
varying stages of the maturation process.
We recently introduced a method for the general ampli-
fication of all polyadenylated (polyA+ ) RNA transcripts in
samples as small as a single cell (Fig. 1) [2]. The poly-
merase chain reaction (PCR) applied to polyA+ RNA
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yields amplified cDNA that is several hundred bases in
length and is representative of the extreme 3' untranslated
ends of the original transcripts. As a result of the length
limitation, the abundance relationships in the original
sample are preserved in the final amplified product. Analy-
sis of gene expression at the level of single cells would
guarantee absolute homogeneity of each source of cDNA,
to a level that could never be attainable by fractionation of
cell populations. However, the advance comes at a cost:
each cell is consumed by the procedure, and its develop-
mental potential can no longer be determined by tracking
its eventual fate.
For the hemopoietic system, an answer to the dilemma
arises from the natural synchrony of development that
is characteristic of growing clones in culture. When pre-
cursor cells are cultured with the required cytokines, they
generate daughter cells. The commitment status of the
daughter cells can be assessed by culturing them in iso-
lation and observing their ultimate outcomes. Most
growth-competent precursors in hemopoietic tissues are
committed to development within a single lineage. Not
surprisingly, daughter cells generated by the first two or
three divisions are typically identical to each other in dif-
ferentiative, as well as growth, potential [3]. They also
retain close cell-cycle synchrony through several divisions,
Fig. 1. General amplification of polyadenylated RNA transcripts.
generally dividing within minutes of each other. If mem-
bers of a clone can be established to be identical to each
other in potential, then it should be possible to use some
cells from a clone as reporters of the probable potential of
siblings that are taken for RNA analysis.
Less predictable results arise when clone formation is
initiated by the smaller number of more primitive pre-
cursors in hemopoietic tissues that have the capacity to
develop into multiple lineages. In the course of initial cell
divisions, such cells can generate daughter cells that are
individually committed to differing lineages [3]. If sibling
cells in some clones prove to differ from one another
in their differentiative potential, they cannot serve as reli-
able indicators of the potential of processed siblings. But
clones whose tested siblings retain pluripotentiality and
which display the same set of differentiative potentials
when subcultured would be useful as indicators of the
likely potential of siblings analyzed for RNA expression.
In this study, we exploited the characteristic synchrony of
clones developing in culture and derived a set of cDNA
samples from individual hemopoietic precursor cells
mapped by sibling analysis to a variety of positions in the
hemopoietic hierarchy. Using probes for genes with well-
understood specificity of expression in the system, we
show the expected hybridization patterns that validate our
assignments. We also present results from a panel of probes
whose RNA-level expression patterns were less pre-
dictable, providing a unique look at stage-by-stage expres-
sion in the system. Finally, we show the results of pilot
efforts at cDNA- and PCR-based subtraction that iden-
tify numerous sequences expressed in one individual cell
but not another. Collectively, these experiments introduce
a new and powerful investigative approach that will allow
the mapping of differentiation in heterogeneous systems at
unprecedented resolution.
Results
Similarity of sibling cells in colony 'starts'
This study was based on a strategy involving the induc-
tion of nascent colony 'starts' from marrow cells in semi-
solid cultures, selection of single cells from a start for
cDNA amplification, and separate secondary culture of
each of the remaining siblings in conditions that support
full development of cells in all myeloid lineages (Fig. 2).
For sibling outcomes to be useful as indicators of the
potential of the processed cells, siblings would have to
have identical outcomes in a high frequency of colony
starts. One set of four- to eight-cell colony starts was
generated from unpurified marrow cells cultured with
either interleukin-3 (IL-3) or granulocyte colony-stimu-
lating factor (G-CSF). Sibling cells grew in the secondary
cultures into erythroid, monocytic, granulocytic or mega-
karyocytic colonies (Table 1). Most starts generated sec-
ondary colonies that represented only a single lineage.
Two lineages were represented in the progeny of only
11 % of starts.
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A second, larger set of colony starts was generated from
cells that were enriched for primitive precursors. Most
were derived from marrow cells that had been cultured
first with IL-1 and IL-3 under thymidine selection to
eliminate actively cycling cells; this treatment enriches
marrow for more-primitive precursors that are known to
cycle less frequently [4]. A small subset came from day 12
fetal liver cells that were sorted for expression of the
AA4.1 surface antigen. Among starts from these popula-
tions, 45 % yielded progeny that represented two lineages
and 17 % yielded subclones of three or more lineages
(Table 1). Overall, siblings generated colonies of identical
composition in 81% of colony starts. Even among
colony starts from cells with two or more potentials,
siblings yielded identical outcomes in 63 % of cases.
These proportions did not differ significantly when four-
to five-cell and six- to eight-cell starts were analyzed
separately (data not shown). Among the instances of
non-uniform outcome from starts of six to eight cells,
half had only a single discrepant daughter outcome. From
the frequencies of disparate results in the secondary cul-
tures, the numbers of cells per start, and the proportions
of differing secondary clones in each disparate start, it is
possible to calculate the probability of mistaken identifi-
cation of a cell sampled for cDNA amplification, given
that all of its siblings display identical outcomes in sec-
ondary cultures. Even in the worst case of multilineage
starts, that probability did not exceed 0.13 in our series
- meaning that less than one in seven multipotential
assignments would be incorrect.
In these experiments, sibling cells from nascent clones
were plated individually into culture conditions that were
designed to support growth and terminal maturation in
all myeloid lineages. Although cells from individual starts
typically generated clones that were identical to one
another in composition, the composition of the secon-
dary clones differed from one start to another. As culture
Fig. 2. Determination of the differentiative potential of hemo-
poietic precursor cells by analysis of the fates of their sibling cells.
(a) Marrow cells are plated in primary cultures and precursor cells
allowed to divide two or three times. The culture plate shown on
the left contains three colony starts each consisting of four cells.
From one of the starts, one cell is withdrawn and lysed for cDNA
amplification. The remaining sibling cells are plated individually
in a gridded secondary culture plate, where each develops with
time into a secondary colony. Analysis of the lineage content of
the secondary colonies establishes the differentiative potential of
each of the cultured sibling cells. If each forms the same kind of
colony, it is likely that the cell processed for cDNA would have
had a similar potential. (b) Identical outcomes of sibling cells
from colony starts. The appearance of the cells in each colony
start is shown at the top. The micrographs show the appearance
of the resulting secondary colonies, with the lineage content
indicated at the bottom (abbreviations as in Fig. 3).
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conditions in the secondary cultures were invariant, the
uniform outcomes within clones provide compelling
evidence for the existence of stable differentiative com-
mitment, whereas the varying outcomes from start to
start must reflect the existence of a variety of distinct
commitment states.
Collection of cDNA samples from cells identified by sibling
analysis
Amplified cDNA was prepared from precursor cells that
were individually drawn from colony starts, and their
likely potential was read from the outcomes of their
sibling cells in secondary cultures. If a resulting cDNA
sample hybridized successfully to probes for the 'house-
keeping' genes L32 (encoding a ribosomal protein) and
gapdh (encoding a metabolic enzyme), and if its cultured
sibling cells had uniform outcomes, the sample was
included in the study without any additional selection
criteria. Terminally maturing cells were sampled from
homogeneous populations growing in bulk cultures, or as
colonies in semi-solid medium, and cDNA was usually
prepared from individual samples of 50-200 cells. Among
the various samples of mature cells, only those from
megakaryocytes were prepared from single cells. As
shown in Figure 3, multiple samples were obtained from
each of 16 distinct positions in the illustrated hierarchy.
By the nature of our approach, all sampled precursor cells
were active in the cell cycle, and information relevant
to cycle phase was often available. Colony starts were
Fig. 3. Hierarchical relationships of the hemopoietic cells
sampled for cDNA. Each circle represents a stage in the
hierarchy. The ghosted circle represents a stage assumed to
exist but not actually sampled. The numbers indicate how
many samples were obtained from each stage. Along the bot-
tom are the samples taken from terminally maturing cells in
each indicated lineage. The topmost circle represents 5
instances of pluripotential precursor cells that were able to dif-
ferentiate into erythroid, megakaryocytic and macrophage lin-
eages. The stage marked El represents hemoglobin-negative
erythroid cells at the proerythroblast/CFUE stage, and that
marked E2 represents hemoglobin-positive normoblasts and
reticulocytes. Meg, megakaryocytes; E, erythroid cells; Neut,
neutrophils; B, B lymphocytes; T, T lymphocytes.
visualized after 26 hours of culture, and after recording
their locations in the cultures they were returned to the
incubator. After an additional 1-2 hours, the plates were
removed from the incubator and cells from the mapped
starts were micromanipulated. The cultured siblings were
then monitored at intervals until they divided. Fre-
quently, starts of four cells when mapped had become
eight cells by the time they were sampled. In other
examples of four-cell starts, the three monitored siblings
divided within 1-2 hours of sampling. Such observations
placed some of our sampled precursor cells in late G2 and
others in early G1 phase of the cell cycle (Table 2).
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Confirmation of stage- and lineage-fidelity of the sample set
using lineage-specific probes
The cDNA samples from the cells summarized in Figure
3 were electrophoresed in agarose gels, Southern blotted,
and hybridized to a set of lineage-specific probes. Because
the polyA-PCR procedure generates a spectrum of 3'
cDNA fragments ranging between 200-600 bases, hybri-
dization signals appeared as correspondingly disperse pat-
terns rather than as single bands. Most samples hybridized
to probes for the L32 and gapdh transcripts.
Lineage-specific probes showed the expected hybridiza-
tion specificities (Fig. 4). Transcripts encoding lysozyme
(lys) and, most notably, myeloperoxidase (mpo), were
expressed very early in granulocytic and monocytic lin-
eages, before lineage commitment was complete (in
agreement with earlier descriptions [5]). Myeloperoxi-
dase activity is not detected, by staining, until later in
maturation in these lineages, stressing the distinction
between RNA, protein and mature protein levels of
expression. The expression of -globin was strong in sam-
ples from terminally maturing erythroblasts, but a low
level of hybridization was also observed in a bipotent
erythroid/megakaryotic precursor. Two samples of lym-
phocytes, grown from fetal liver precursors, showed asyn-
chronous expression of rag-2 and Ig (immunoglobulin
gene expression was analyzed using a probe from the CpI
locus). The rag-2 transcript encodes a protein that is
involved in immunoglobulin locus rearrangement, and is
expressed in B-lymphocyte development before Ig; the
asynchrony observed here is likely to reflect differences
in maturity of the two cultures. Supporting this sugges-
tion is the correlation between the expression of rag-2
and c-myb in the same samples (Fig. 5). As expected
[6,7], the highest levels of ick expression were detected
in T lymphocytes.
Overall, the results were compatible with our distinctions
between precursors and terminally maturing cells. They
also affirmed that our lineage assignments were correct
and that mRNA sequences were faithfully preserved
through the amplification procedure.
Mapping of gene expression patterns over the sample set
A large and growing number of genes are known whose
products are involved in differentiation, growth, self-
renewal or signalled cell death in hemopoietic cells.
Although information is available on the stage- and
lineage-specificity of RNA expression for many of these,
the data have generally been derived from cell popula-
tions, frequently from immortalized cell lines, and little
information is available on lineage- or stage-specificity in
the normally differentiating hierarchy. As our panel of
cDNA samples spanned a detailed spectrum of differen-
tiation stages, we anticipated that hybridization analysis
would extend our knowledge of expression patterns and
possible roles played by the genes tested. Moreover, if our
results matched specificities reported previously, the data
Fig. 4. Hybridization of probes for constitutive 'housekeeping' and lineage-specific genes to cDNA samples from diverse stages in the
hemopoietic cell hierarchy. cDNA samples from the indicated cell types and stages were electrophoresed and Southern blotted. Barsjoin samples derived from sibling cells drawn from the same colony starts. The top row shows the set of samples stained with ethidium
bromide before blotting, and indicates that roughly equivalent amounts of amplified cDNA were loaded in each lane. The rest of the
figure shows hybridization of the indicated radiolabelled probes to each cDNA sample. For details of cells and culture conditions, see
Materials and methods. Abbreviation as in Fig. 3, plus: M-CSF, macrophage colony-stimulating factor; ConA spleen, T lymphocyes
grown from adult spleen cells stimulated with the T-cell mitogen concanavalin A.
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would add to our confidence in interpreting novel results
obtained with the system.
Hybridization results obtained with a broad panel of
genes are shown in Figure 5. The first seven rows show
patterns for a selection of genes that encode products
involved in the control of gene expression, growth and
differentiation. The c-myb gene encodes a transcription
factor that is known to be expressed in immature hemo-
poietic cells [8]; its transcripts were detected broadly in
pluripotential precursors, and in committed precursors
transcripts were detected mainly in granulocytic and
monocytic cells. Among maturing cells, expression was
confined principally to growing B lymphocytes.
The RB-1 protein is a link in a chain that regulates entry
of cells into the S phase of the cycle [9]. The expression
of RB-1 is upregulated in murine erythroleukemia
cells after the induction of maturation [10], and blood
cell formation is defective in RB-1-/ - mouse embryos
[11,12]. Observations in chimeric RB-1-/-/RB-1 +/ +
mice have suggested that the essential function provided
by RB-1 may not be intrinsic to hemopoietic precursors
[11,12]. Expression of RB-1 predominated in pluripo-
tential and committed precursors of the erythroid and
megakaryocytic lineages (Fig. 5). This result provides
direct evidence for the expression of RB-1 RNA in
normal hemopoietic precursors, and specifically in pre-
cursors with erythrocytic and megakaryocytic potential.
Fig. 5. Hybridization of probes for regulatory and structural genes to the cDNA sample set. Abbreviations as in Figs 3,4.
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The observation suggests that RB-1 may indeed play a
direct role in early erythroid differentiation, and would
be compatible with a direct basis for the defective blood
cell production observed in RB-I - /- embryos.
The p53 protein plays a role in signalling events that lead
to cell death after DNA damage or cytokine withdrawal
[13,14]. Its presence has been demonstrated directly in
enriched marrow precursors [15,16], but not in mature
myeloid cells. Our observations add further detail, show-
ing p53 expression throughout pluripotential and com-
mitted myeloid precursor stages in neutrophil, monocyte
and erythroid lineages (Fig. 5). Expression persisted in
growing T lymphocytes, and at lower levels in B lym-
phocytes and macrophages, but was not detected in
terminally maturing megakaryocytes, neutrophils or ery-
throid cells that lacked further growth potential. This
expression pattern would be consistent with a role for
p53 in the signalled death of growing hemopoietic cells
on cytokine withdrawal.
GATA-1 is a zinc-finger transcription factor [17], and
SCL [18] and Id-i [19] are of the helix-loop-helix
(HLH) family of transcription factors; all are expressed in
immature hemopoietic cells. Id-l lacks a DNA-binding
domain but retains the capacity to hetero-oligomerize
with, and thereby inactivate, other HLH family mem-
bers. Transcripts of scl and gata-1 were detected broadly
in pluripotential and committed precursors, but persisted
only into maturing cells in the erythroid, megakaryocytic
and mast cell lineages (Fig. 5). Pluripotential cells also
expressed id-I, but we observed a lower frequency of
expression in committed progenitors. In maturing cells,
id-I transcripts were detected in B lymphocytes and, at a
very low level, in growing macrophages, but not in com-
mitted and maturing erythroid, megakaryocytic and mast
cells. Fra-1 is a Fos-family AP-1 transcription factor [20],
expression of which in hemopoietic cells has not been
reported previously. We detected generalfra- 1 expression
in early myeloid precursors, but persistence only into the
B-lymphocyte lineage (Fig. 5), a pattern shared with id- 
and c-myb.
Figure 5 also shows hybridization patterns of probes for
transcripts for three cytokine receptors. Expression of
c-fms is known to be restricted to cells of the monocytic
lineage [21]. We detected c-fms transcripts in precursors
committed exclusively to monocytic differentiation, but
not in earlier pluripotential precursors; expression persisted
into maturing monocytic cells, as expected. The absence
of detected c-fins transcripts in immediate bipotential pre-
cursors of the lineage or earlier cells was unexpected. The
observation suggests that the expression of c-fms may be
upregulated only after commitment to the monocyte line-
age, and that the receptor it encodes may therefore be
excluded from a role in earlier decision processes.
The erythropoietin receptor (EpoR) is known to be
expressed in cells near the CFUE/proerythroblast stage
of the red-cell lineage and, as expected, we observed
strongest hybridizations to samples from this stage. Weak
hybridization signals were also detected in 3 out of 12
pluripotential erythroid precursors, although early pre-
cursors are not known to be directly responsive to ery-
thropoietin. The receptor encoded by c-kit plays an
essential role in growth and maintenance of primitive
hemopoietic precursors and also in early steps in the
erythroid lineage [22]. Hybridization to our probe was
detected in bipotential and committed precursors in vari-
ous lineages, but was weak to undetectable in mast cells
and other terminally maturing populations. The sensitiv-
ity of this probe was reduced as a result of the high
proportion of A and T residues in the 3' untranslated
region of the target cDNA.
Most of the other genes whose hybridization results are
shown in Figure 5 are known to be expressed in hemo-
poietic cells, but little information is available concerning
their stage- and lineage-specificity. The genes bcl-2 and
bax encode components of a system that controls sig-
nalled cell death in T and B lymphocytes and in myeloid
leukemias [23,24]. Bcl-2 inhibits signalled death by
heterodimerizing with Bax [23]. There is evidence that
the p53 protein upregulates the expression of bax and
represses that of bcl-2 [25]. We detected bcl-2 transcripts
in monocytes and their committed precursors, and in
growing lymphocytes, but not in other lineages or in
most pluripotential precursors. In contrast, bax transcripts
were nearly universally expressed. Our findings are com-
patible with the suggested relationships between the
expression of p53 and bax/bcl-2, and suggest that the
involvement of Bcl-2 in regulation of myeloid precursors
may be confined to the monocytic lineage.
The phosphatase encoded by syp is known to be widely
expressed in hemopoietic lineages [26], and our blots
confirmed its expression in all of our samples including
pluripotential and unipotential precursors (Fig. 5). The
murine probe to facc - the gene defective in human
Fanconi anemia (group C) [27] - hybridized strongly
but at low frequency among pluripotential precursors,
and weakly to samples from growing B and T lymp-
hocytes and monocytes. This pattern - intense expres-
sion in a minority of precursor samples and lower-level
expression in growing, terminally differentiating popu-
lations of monocytes and lymphocytes - resembles that
of bcl-2. The protein tyrosine phosphatase encoded by
ptplc has been mapped recently to the motheaten locus in
the mouse [28]; the defective allele leads to a syndrome
involving excessive numbers and constitutive activation
of tissue macrophages. Like facc, ptp Ic transcripts are dif-
ficult to detect in RNA from whole bone marrow. Our
blots detected ptplc expression in unipotential progeni-
tors of monocytes and neutrophils, and in earlier pluri-
potential hemopoietic precursors. CD45 also encodes
a widely expressed hemopoietic protein phosphatase
that is anchored in the surface membrane [29]. Tran-
scripts were detected in precursor cells at each stage, but
in maturing cells persisted only in the monocytic and
lymphoid lineages.
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We also probed for transcripts encoding cell-surface or
structural proteins that are often used for phenotypic
characterization of hemopoietic cells. The transport pro-
tein encoded by mdr-1 confers multiple drug resistance
when overexpressed [30]. Transcripts were expressed in
precursor samples throughout the hierarchy, as well as in
growing, terminally maturing cells in all lineages (Fig.
5). Ly6A (Sca-1) encodes a surface antigen that is known
to be expressed on lymphocytes and monocytes [31],
and in certain mouse strains it also marks primitive mul-
tipotential stem cells that have long-term in vivo recon-
stitution capacity [1,32]. Our samples were derived from
CBA/J mice whose stem cells are not marked. Among
precursor cells, only those committed uniquely to mono-
cyte differentiation contained detectable transcripts, as
did maturing monocytes and lymphocytes, as expected.
Fig. 6. Isolation of differentially expressed cDNAs by subtractive
hybridization. The diagram illustrates the specific isolation of
sequences present in the 'tracer' cDNA sample but not in the
'driver' sample A. Sample A is amplified using a primer contain-
ing a unique sequence, X, and is then biotinylated. Sample B is
amplified using a primer that contains. a unique sequence, Y.
After hybridization of B with an excess of A, streptavidin is added
and the mixture is extracted with phenol. The avidin localizes to
the phenol phase, taking with it the biotinylated cDNA from A
together with sequences from B that have hybridized to A. Unhy-
bridized cDNA from B remains free in the aqueous phase, and is
specifically amplified using a primer containing the sequence Y.
The FcyRII3 I probe detects transcripts encoding a class
of low-affinity cell surface receptors which recognize the
Fc portion of IgG. The probe also detects FcyRIII tran-
scripts, which encode a second low-affinity receptor for
IgG and IgE [33,34]. FcyRII/III transcripts were detec-
ted in monocytes, as expected [33], but not in lympho-
cytes. Transcripts were also detected in early pluripo-
tential and committed precursors of granulocytic and
monocytic lineages, but not in erythroid or megakary-
ocytic precursors. Although FcyRII/III transcripts have
been detected in an enriched murine marrow precursor
population [35], this is the first description of their dif-
ferential expression in precursors of differing commit-
ment states. If accompanied by protein expression, this
would have practical implications for experiments in
which antibodies are used to mark precursor cells, and it
also suggests a potential strategy for the separation of
neutrophil and macrophage progenitors from erythroid
and megakaryocyte precursors.
The cytoskeletal 3- and y-actins are the major com-
ponents of microfilaments. Although the relative levels of
3- and y-actin mRNA [36,37] and protein [38] are known
to differ in different cell types and tissues, little is known
of their expression patterns in hemopoiesis. The p1-actin
gene was generally expressed in growing cells throughout
the hierarchy (Fig. 5). In contrast, y-actin expression was
detected mainly in precursor cells, particularly in commit-
ted megakaryocytic, monocytic and granulocytic precur-
sors; among maturing cells, expression persisted only in
Concanavalin-A-stimulated T cells. These results add sup-
port to the notion that the two actin isoforms may have
distinct functions [39]. Together, the results add significant
detail to our knowledge of expression of these genes in
normal precursor populations.
Identification of genes expressed at specific stages in the
hierarchy by subtractive hybridization
In order to isolate sequences that are expressed at specific
stages in the hierarchy, we developed a protocol for sub-
tractive hybridization that builds on advantages inherent
in PCR-derived samples (Fig. 6). Essential features are
the availability of'driver' and 'tracer' cDNA in unlimited
quantities, the specific amplification of unhybridized tra-
cer sequences using a primer that distinguishes them
from driver sequences, and the specific generation of
unlimited quantities of subtraction product from even
molecular amounts of unhybridized tracer.
To test the utility of the approach, we conducted a pilot
experiment in which a cDNA sample from a bipotential
neutrophil/macrophage precursor (driver) was subtracted
from an erythroid/megakaryocyte precursor sample (tra-
cer), and a second experiment in the reverse orientation.
Difference sequences were subjected to a total of five
rounds of sequential hybridization and reamplification.
The final result from each orientation was cloned into a
plasmid library, and 48 cDNA clones were picked at ran-
dom from each. Dot blots were prepared from the sam-
pled cDNA clones and hybridized to probes prepared
A-'Driver' source B-'Tracer' source
AmplifycDNA(X) 1[
-biotin cDNA(Y)
Driver. Tracer
Hybridize
..... .........
,.. .Ns· . · .,. i /
:/ . /
Aqueous
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Phenol/avidin
I
I PCR (Y)
Amplified difference I \\
sequences from B /\
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from total driver or tracer cDNA; 10-30% of clones
hybridized to tracer but not driver. The remainder of the
cDNA clones reflected the incomplete removal of shared
sequences or contamination of the subtracted samples
with inappropriately amplified driver sequences. Cross-
hybridization experiments showed that the selected sets
were almost entirely non-redundant.
To obtain a broader picture of specificity of expression of
the selected clones within the hierarchy, they were indi-
vidually labelled and hybridized to the master sample set.
A sampling of the results is shown in Figure 7. Included
are examples hybridizing to tracer but not driver, hybri-
dizing to driver but not tracer, hybridizing to both, and
hybridizing uniquely to the single cDNA sample from
which the cDNA clone arose. Although numerous
cDNA clones were identified whose expression differed
between the individual cells that originated the driver and
tracer cDNAs, only one example (gb32) was identified
that was expressed in one precursor cell class but not in
any other members of the precursor class exemplified by
the subtraction partner. The clones m13 and gb32 show
patterns of specificity that make them attractive candidates
for further investigation. An unexpected observation was
that many of the probes derived from the two precursor
cells hybridized strongly to hemopoietic precursors but
not to maturing cells in various lineages, even though
many of the latter examples were still actively growing
when sampled.
These results show that it is feasible to perform subtractive
hybridization on cDNA samples derived from single cells,
and that the procedure can yield difference sequences in
substantial numbers. Transcripts that are uniquely expres-
sed in rare progenitor cells may be too dilute in conven-
tionally purified populations or cell lines to be captured
with standard approaches. Our approach avoids dilution
by non-desired cell types, and maximizes the opportunity
of capturing precursor-specific transcripts. Moreover,
once a difference tag is identified, it can be rapidly
screened for consistency and specificity of expression by
hybridization to the set of lineage- and stage-specific
cDNA samples.
Discussion
This study introduces a novel system for high-resolution
mapping of gene expression in a complex cellular hierar-
chy. The system is -based on three principal elements.
First, a polyA-PCR technique provides for unbiased
amplification of all polyadenylated RNA transcripts pre-
sent in a cellular sample, preserves abundance relation-
ships, and performs reliably with samples as small as a
Fig. 7. Expression patterns of probes obtained from subtractive hybridization of cDNA from two individual cells. The cDNA
preparations from a single E/Meg precursor and from a single Neut/Mac precursor, indicated with arrows, were subtractively
hybridized in both possible orientations. The difference cDNAs were cloned into libraries and individual clones were randomly
isolated, radiolabelled and hybridized to Southern blots as in Figs 4-6. Abbreviations as in Figs 3,4.
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single cell. The resulting samples are permanently renew-
able by reamplification. Second, the technique is applied
to rare precursor cells of diverse developmental potential
by sampling them as single cells, thereby assuring homo-
geneity of the source of amplified cDNA. Third, sam-
pling of single cells is coupled with direct observation of
the biological potential of sibling cells, which thus serve
as reporters of the probable biological potential of the
processed cells.
We used the cDNA set as a matrix for mapping the
stage- and lineage-specificity of expression of a large
selection of genes. In returning answers expected on the
basis of earlier work in conventional systems, the results
confirmed the coherence and fidelity of the amplification
procedure, and the accuracy of our phenotypic assign-
ments based on sibling outcomes. A selection of illus-
trative results is shown schematically in Figure 8. We
detected general expression of p53 in precursors; expres-
sion was downregulated in mature progeny that lack fur-
ther growth potential. RB-1 illustrates an unexpectedly
specific pattern that was confined principally to erythroid
and megakaryocytic cells and their uncommitted pre-
cursors. The expression of FcyRII I also presented an
unanticipated pattern of specificity among pluripotential
and committed precursors.
We also tested the ability of cDNA-based subtractive
hybridization to select transcripts expressed in one pre-
cursor cell and not in another. Difference transcripts
were readily identified, and further information on their
specificity was gained by probing for their expression in
the master sample collection. The hybridization pattern
of one such clone, gb32, is also shown in Figure 8.
Sequence analysis of these clones suggests that many will
turn out to represent previously unreported genes (data
not shown).
A striking observation in this study was the marked
variability of hybridization of many of our probes to
cDNA samples derived from cells that ostensibly shared
the same developmental potential. Several possible sources
of the variation can be envisioned. Variability might be
generated artefactually during reverse transcription and
amplification in vitro. A number of observations suggest
that this is not the case. First, the same samples hybridized
probes for constitutively expressed genes, such as L32,
gapdh, syp and others, with relative uniformity. Moreover,
control experiments were performed in which lysates
were prepared from 100 pooled cells and then distributed
in aliquots representing as little as 1/200 of the total, prior
to reverse transcription and general amplification. Vari-
ability in sample-to-sample hybridization should be repro-
duced in such experiments if it arises in the process of
amplification from small amounts of template, but should
not be otherwise observed because each aliquot should
be identical. Variation in probe-hybridization to these
samples was relatively minor compared to the variation
observed in samples prepared from single hemopoietic
precursors, even where the amount of template used in
the pooled controls was less than a single cell-equivalent.
We have reported previously that this procedure preserves
relative abundance relationships, even when initiated
with amounts of template typical of single cells, and that
sensitivity of detection extends at least to transcripts
represented at an initial abundance of 0.25 % [2]. Given
the relative constancy of hybridization of the same sam-
ples to probes for constitutively expressed genes such
as L32 and gapdh, the repeatedly observed preservation
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Fig. 8. Examples of differing expression
patterns within the hemopoietic cell
hierarchy. Expression patterns shown in
Figs 5, 6 and 8 are positioned schemati-
cally on the sample hierarchy illustrated
in Fig. 3. The solid black pattern repre-
sents strong hybridization, grey weaker
hybridization, and white undetected
hybridization. The proportions of the
sample sets labelled at each position
are indicated by the sector sizes. For
example, the p53 probe hybridized
strongly to four of seven cDNA samples
from bipotential erythroid/megakary-
ocyte precursors, and more weakly to
one of them. Abbreviations as in Fig. 3.
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of abundance relationships (especially in samples drawn
from cell populations) and the apparent sensitivity limits,
we conclude that threshold effects are unlikely to account
for extremes of intense hybridization alternating with
undetectable hybridization - seen, for example, with
the probes for bcl-2 andfacc.
Another possible source of variation to be considered is
position in the cell cycle, an issue which will require sys-
tematic experimental analysis. However, we observed
marked variation even in cDNA samples derived from
siblings that were positioned within minutes of each
other in the cell cycle. Moreover, although we knew that
some of the cells were sampled in late G2 and others
in early G1, corresponding correlations with expression
were not observed. Finally, we consider that marked
fluctuation in transcript abundance may be an inherent
aspect of the transcription process itself. Transcription
complexes assemble by random collisions of multiple
proteins with promoter/enhancer sites, their transcrip-
tional activity can pause, and formed complexes can dis-
sociate. Because only two such complexes can exist in a
diploid cell for a given gene, the timing of transcriptional
activity is bound to be stochastic [40,41]. If the intervals
between active transcription are significant relative to
transcript half-lives, large temporal variations in transcript
concentrations would result which would be observable
in individual cells but not in populations. Although this is
our favoured explanation, proof will require exclusion of
the alternatives.
Whatever its sources, sample-to-sample variation in
hybridization has practical implications for experimental
design and interpretation. Assessment of the expression of
a gene at a particular developmental stage requires the
analysis of adequate numbers of individual cDNA sam-
ples. Intensity of expression may be better inferred from
the proportion of positive hybridizations within a set of
samples than from the intensity of individual hybridiza-
tions. High sample-to-sample variations may obscure cor-
relations in expression of different genes if looked for only
at the single-cell level; significant correlations should
however become apparent at the level of sample sets. Sim-
ilarly, if subtraction is to be used to identify differences in
gene expression between two developmental stages, it
should be performed with pools of individual cell samples
to avoid the 'quantum noise' that would be generated
by subtraction of single-cell samples. Numerous clones
yielded by subtraction of cDNA from single cells repre-
sented true expressional differences between the individ-
ual subtraction partners, but not true differences between
the developmental stages they represented (see Fig. 7).
In the course of this study, we frequently encountered
extreme examples of intermittency in which individually
cloned transcripts hybridized strongly to cDNA from
their cell of origin but not to our other cDNA samples
(for example, fb24; see Fig. 7). It is possible that such
instances reflect low-probability events that have no
important role in cell function. Together they would
contribute to a significant background of 'inappropriate'
transcripts that are readily detected in individual cells but
not in cell populations.
The polyA-PCR procedure has unique advantages in a
wide variety of settings. Applied to populations, polyA-
PCR requires only a few cells and yields hybridization
results quantitatively similar to those obtainable with bulk
mRNA, with comparable limits of sensitivity [2]. Applied
to single cells, it can be used to investigate transcriptional
frequencies, simultaneous expression patterns of any
desired number of genes and, most importantly, allows
the preparation of cDNA from absolutely homogeneous
cell sources even when those cells are drawn from mixed
or asynchronous populations. Once generally amplified
cDNA is made, specific PCR can be applied to detect
species that are too rare to be detectable on Southern
blots of the'primary cDNA samples (EB., unpublished
observations). Amplified cDNA also has unique advan-
tages as a starting point for subtraction. As rare unhy-
bridized sequences can subsequently be reamplified, sub-
tractive approaches have a high degree of sensitivity, and
exhaustive subtraction with repetitive rounds of subtrac-
tion and reamplification becomes feasible without con-
cern fr quantity of subtracted material. As an alternative
to subtraction, differential display can also be applied to
amplified cDNA pairs for rapid identification, particularly
of higher-abundance differences [42].
The experiments described here have also identified
directions for further refinement of the procedures. The
polyA-PCR protocol amplifies only a few hundred bases
of 3' terminal sequence, preserving relative abundance
relationships but sacrificing direct access to coding
regions. Recently described strategies relieve the length
constraints on the PCR procedure and are likely to be
applicable to polyA-PCR [43]. The subtractive protocol
can also be made more efficient than the double-stranded
procedure described here. Preliminary experiments indi-
cate that nearly complete subtraction of shared sequences
is possible with only one round of hybridization to
single-stranded driver cDNA.
Conclusions
This study was designed to determine patterns of gene
expression within a multilineage precursor hierarchy,
using a novel approach to resolve precursors at individual
developmental stages. The results established that a pro-
cedure for universal amplification of polyadenylated
mRNA can be applied productively to single hemopoi-
etic precursor cells and can be used to analyze much of
the transcriptional repertoire in each cell examined. The
experiments also established that sibling cells in colony
starts can report reliably on the developmental potential
of a single cell taken for PCR. By combining global
cDNA analysis of single precursor cells with the identifi-
cation of their potential by sibling analysis, it was possible
to map expression, at the RNA level, of a large panel of
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genes known to be involved in hemopoietic cell growth,
differentiation or function. The results supply the first
view of expression of these genes at a level of resolution
that distinguishes precursor cells in differing commitment
and maturational states, and thus provide insights into
specificity of expression that were not available previously.
Subtractive hybridization of cDNA from one precursor
cell from that of another representing a different commit-
ment state can provide a rich harvest of differentially
expressed transcripts, and it appears that many will prove
to be novel. By hybridizing the difference transcripts to
the master set of precursor cDNA samples, those with
interesting and consistent patterns of specificity over the
entire lineage tree can be rapidly identified.
Materials and methods
Cells and cultures
Marrow cells were flushed from femurs of 8-12-week-old
CBA/J mice. Where indicated, cells were enriched for primi-
tive, more slowly cycling cells by incubation for 20 h with
100 jig mnl7 thymidine in IMDM with 5 % FBS, 1 ng mi-1
human IL-13 and 15 U m-1 IL-3, as described [4]. Liver cells
were obtained from day 12 C57BL/6J fetuses and subsequently
enriched by panning for B220+ cells, or for B220-/Mac-l-,
AA4.1+ Ly6A * cells containing bipotential precursors of B cells
and macrophages, as described [44].
Colony starts were initiated in 'complete' methyl cellulose
cultures containing IMDM, 4 % FBS, serum fraction V, lipids,
transferrin, insulin, 15 % conditioned medium from human
5637 cells, IL-1, IL-3, murine c-Kit ligand and erythropoietin,
as described [1,4]. Where indicated, cultures contained only
G-CSF, or only IL-3, without the other hemopoietic cytokines.
Terminally maturing erythroid cells, megakaryocytes, neu-
trophils and macrophages were sampled from single-lineage
colonies grown from marrow-cell precursors in methyl
cellulose containing IL-1, IL-3 and erythropoietin. Where
indicated, some macrophage colonies were grown in the addi-
tional presence of L929 cell-conditioned medium as a source
of M-CSF. Maturation state and lineage composition were
assessed by examination of May-Grunwald-Giemsa-stained
spreads from the same colonies. Maturing B cells were sam-
pled from bulk 7-day cultures of B220' fetal liver cells grow-
ing in response to IL-7, as described [44]. Maturing B cells
and macrophages were also taken from clonal liquid cultures
initiated from single bipotential precursors purified from day
12 fetal liver [44]. B-cell subcultures were grown with IL-7
and fibroblast feeder cells and sampled 12-15 days after initia-
tion from fetal liver. Macrophage subcultures were grown
with M-CSF, IL-3 and c-Kit ligand and sampled at 14-20
days, as described [44]. T cells were taken from 4-day cultures
of adult spleen cells growing in response to 2 Lg ml-1 con-
canavalin A. Mast cells were sampled from bulk cultures of
adult marrow cells passaged for 25-46 days in IMDM contain-
ing 15 U ml1-' IL-3, 2 g ml- l concanavalin A, 1 % FBS,
0.05 % bovine serum fraction V, 5 ig ml- l transferrin and
5 jig ml-1 insulin. Homogeneity was assessed by staining with
Alcian Blue [45].
Sibling precursor cells from colony starts were plated in
gridded plates in complete methyl cellulose. Secondary
colonies were visualized daily and sampled for morphological
assessment when growth ceased. Peripheral cells from large
colonies that were still growing at 6-7 days were sampled for
morphology and specific staining at that time, and at 2-3-day
intervals until growth stopped. Cell morphology was evaluated
after staining with May-Grunwald-Giemsa. Megakaryocytic
cells and precursors were identified by histochemical staining
for acetylcholinesterase [46], and mast cells were identified by
Alcian Blue staining. Some colonies that were composed pre-
dominantly of terminally maturing neutrophils at 6-8 days
were overgrown in the succeeding week by slowly-dividing,
highly refractile cells that were tentatively classified as mast cells
or eosinophils, without confirmation by specific staining.
General amplification of cDNA
The procedure is shown schematically in Fig. 1 and described
in detail elsewhere [2,47]. Briefly, cells were lysed in a small
volume of buffer containing NP40 detergent and RNAse
inhibitors; cDNA with an average length of 400 bases was
generated on the liberated mRNA templates with reverse
transcriptase and an oligo(dT) 24 primer. After addition of a
homopolymeric 3' (dA) tail with terminal deoxynucleotide
transferase, the resulting cDNA mixture was amplified by
PCR using a 3'(dT)24-containing 60-base primer [47]. Addi-
tional quantities of amplified cDNA were generated as
required by reamplification using the same primer [47]. Rela-
tive hybridization patterns of various probes did not change
with repeated reamplification.
Southern blotting and probing
Amplified cDNA, normally 0.1 pg per lane (0.5 jIg for mpo, ck,
id-1, s, gata-1, b-2,facc, ptplc, CD45, mdrl, Ly6A, FcyRI3 1),
was electrophoresed in 1.5 % agarose in Tris-borate buffer,
denatured in NaOH/NaCl and transferred to HybondN+ nylon
membranes (Amersham) as described [47]. Probes labelled with
32p were prepared by random priming (Oligolabelling Kit,
Pharmacia) from templates which included the extreme 3'
untranslated sequences of the genes of interest. Hybridization
and washing were carried out as described [47]. Digitized
images of labelled blots were obtained from PhosphorImager
screens (Molecular Dynamics) for gata-1, id-I and s, or by
digital densitometric scanning of autoradiograms (Computing
Densitometer, Molecular Dynamics) for all other probes.
Probes
Unless otherwise noted, probes were derived from the
corresponding murine cDNA's and contained terminal 3'
untranslated sequence located no more than 50 bp from the
polyadenylation sites; each was validated by size determination
and hybridization to appropriate positive and negative controls.
The sequence references are indicated together with the donors
of probes whose gifts are gratefully acknowledged: ribosomal
L32, murine genomic 1.6 kb Sad fragment encompassing the
final exon ([48]; C. Paige); gapdh, rat 1.3 kb cDNA ([49]; P.
Dubrevil); mpo, human cDNA, 2 kb EcoRI fragment, pMP503
([50]; ATCC); lysozyme M (lys), 500 bp 3' EcoRI fragment
([2,51]; M. Cross); 3-globin, 1.6 kb 3' HindII-Aat2 fragment
[52]; rag-2, 2.0 kb ([53]; D. Schatz); Ig (Cp), 300 bp 3' PstI
fragment ([54]; G. Wu); ck: 30 bp synthetic oligonucleotide
200 bp upstream of the polyA tail [55,56]; c-myb, 600 bp 3'
BglII fragment ([57]; ATCC); p53, 720 bp 3' fragment (D.
Monroe and S. Benchimol, unpublished); RBI, 950 bp 3'
ScaI-HindIII fragment (P. Hamel and R.A. Phillips); id-l,
927 bp full-length fragment including 3' untranslated region
([19]; H. Weintraub); s, 438 bp fragment, 46 bp upstream
of the polyadenylation signal, prepared by PCR (T.H.) [58];
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gata-1, 443 bp terminal 3' fragment, prepared by PCR (T.H.)
[59];fral, 444 bp 3' XbaI fragment ([20]; E. Wagner); c-kit, 315
bp 3' fragment prepared by PCR and confirmed by sequencing
(G.B.); EpR, 1.75 kb fragment ([60]; G. Wong); cfms, 450 bp 3'
Apll-EcoRI fragment ([21]; T. Pawson); bax, 943 bp terminal
EcoRI fragment ([23]; Z. Oltvai and SJ. Korsmeyer); b-2,
841 bp fragment ending 150 bp upstream from the polyA tail
([61]; Z. Oltvai and SJ. Korsmeyer);facc, 708 bp 3' NheI-EcoRI
fragment [27]; ptplc, 1.9 kb fragment, ending 100 bp upstream
from the polyA tail [28]; syp, 2.0 kb fragment, ending 100 bp
upstream from the polyA tail [62]; CD45, 295 bp 3'
BamHI-ClaI fragment ([29]; Ly5-68, ATCC); mdrl, 4 kb
HindIII-EcoRI fragment ([30], P. Gros); Ly6A.2, 6.3 kb EcoRI
fragment ([31], A. Bothwell); FcgRII[31, 1.3 kb PstI fragment
([63]; P. M. Hogarth); 3-actin, human cDNA, 404 bp EcoRI
fragment ending 200 bp upstream from the polyA tail ([64]; L.
Kedes); and y-actin, human cDNA, 322 bp EcoRI fragment
ending 200 bp upstream from the polyA tail ([65]; L. Kedes).
Subtractive hybridization
The following procedures were used to enrich for cDNA
species present in sample A but not in sample B. The general
procedure is adapted from [66]. Tracer cDNA was prepared
from sample A in a conversion reamplification using 'KV(dT)'
primer- (3'-5' (dT) 24 CTTAAGTAGAGGGATATCACT-
CAGCATAATCAATGG) -L for 30 cycles (94 °C 1 min, 42
or 50 °C 2 min, 72 °C 2 min). Driver cDNA was prepared
from sample B using 'NotI(dT)' primer - 3'-5' (dT) 17 CGCC
GGCG) for 30 cycles (as above). The converted driver and
tracer cDNAs were purified from primers and enzymes (Qiagen
Q100 columns, from Qiagen, or Wizard PCR Prep columns,
from Promega, respectively) and final DNA concentration was
determined by OD26 0.
Driver cDNA was photobiotinylated following the general
procedures described in [66]. cDNA (20 pLg) in HE buffer
(10 mM EPPS (Sigma), 1 mM EDTA, pH 8.0) was boiled for
2 min and then kept immersed in ice water. Biotin Photoacti-
vatable (40 ng; Calbiochem) in water was added and the mix-
ture was directly illuminated (optimum wavelength 350 nm)
using either a GE RSM 11OV 275W sun lamp at a distance of
10 cm or an unfiltered 12V 75W halogen projector lamp. After
15 or 30 min, respectively, an additional 40 ng photobiotin
was added and irradiation was continued for 5 or 10 min. An
equal volume of 200 mM TrisHCI, pH 9.0 was added to stop
the reaction. Unbound biotin was repeatedly extracted in equal
volumes of TE-saturated 2-butanol until the organic phase
was uncoloured. After chloroform extraction, the derivatized
cDNA was precipitated overnight with LiCI/ethanol, cen-
trifuged, washed in 70 % ethanol and pelleted again to yield a
distinctly orange-red pellet.
For hybridization, 4 000 ng biotinylated driver and 200 ng
tracer were suspended in 50 p.l HE buffer with 5 Lg tRNA
(Sigma). The mixture was brought to 100 C for 2 min, chilled
and precipitated in ethanol/acetate overnight. The pellet was
dissolved in 4 l 5/4 hybridization buffer (EPPS/EDTA/SDS);
1 pI. 5 M NaCl was added, followed by an overlay of mineral
oil, and the mixture was brought to 100 °C for 5 min. Hybri-
dization was carried out at 68 C for 48 h in a final buffer com-
position of 10 mM EPPS (pH 8.25), 1 mM EDTA, 1 % SDS
and 1 M NaCl. Extraction buffer (95 p.1; 50 mM EPPS, pH
8.5, 500 mM NaCl, 2 mM EDTA) was then added.
For isolation of unhybridized tracer species, 20 R1 of the
mixture was withdrawn to a fresh tube and diluted to 100 ,ul
with extraction buffer. Streptavidin (Sigma) (4 pIg from
4 mg ml- in 50 mM EPPS, pH 8.25, stored at 20 °C) was
added. After incubation for 2 min at room temperature, the
mixture was extracted with 100 I TE-saturated phenol/chlo-
roform, vortexed and centrifuged. From the aqueous super-
natant, an aliquot of 80 p.1 was withdrawn, carefully avoiding
the interface where biotinylated driver and hybridized tracer
were concentrated. Extraction buffer (25 Il) was added to the
phenol/chloroform, vortexed and centrifuged, and an addi-
tional 20 p.l aqueous supernatant harvested. The 100 ,. aque-
ous material was subjected to an additional round of strepta-
vidin addition and phenol/chloroform extraction as above, and
then a final round of extraction with phenol/chloroform fol-
lowed by chloroform alone. From a 5 p.l aliquot, tracer species
were specifically reamplified in a 100 zl PCR reaction primed
with 'KV' primer - 3'-5' GATATCACTCAGCATAAT-
CAATGG, lacking the 3' oligo(dT) sequence but identical in
5' terminal sequence to the Kv(dT) primer - for 30 cycles
(94 °C 1 min, 50 °C 2 min, 72 °C 2 min). The resulting
amplified difference cDNA was subjected to four additional
rounds of subtraction against driver.
For library cloning, amplified difference cDNA was cleaved
within the KV(dT) primer sequence with EcoRI, purified to
eliminate the liberated primer fragment, and ligated into
EcoRI-digested, dephosphorylated pBlueScript II KS+ plasmid
(Stratagene) following procedures as detailed [47].
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